Our comparison showed that patients with higher LRP1 expression levels had higher tumor grade (p<0.001), advanced clinical stage (p<0.001), and were more likely to have lymph node metastasis (p<0.01) and lymphovascular invasion (p<0.05) Figure 2A. The gene discussed is LRP1; the disease is neoplasm.